Dren Bio News and Activities

Dren Bio is owned by Mission BioCapital. Mission BioCapital has a direct presence in 2 countries.

Mission BioCapital has 20 subsidiaries including Alessa Therapeutics, Avvio Medical and Avvio Medical AMEA.

They are in:

• Biotechnology76%
• Healthcare10%
• Other14%

Acquisition, funding and merger involving Mission BioCapital.

• Sanofi has announced the acquisition of Dren Bio  (posted on December 18 2025).

View the org chart displaying its 20 main executives

Most searched biographies at Dren Bio

• Nenad Tomasevic, Chief Executive Officer
• Gorjan Hrustanovic, Director
• Chandra Leo, Board Director

Create your alert
to follow the executive moves at Dren Bio.

Mission BioCapital has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Dren Bio

• News / Dren Bio

Social media about Dren Bio

• Dren Bio on Wikipedia, Google News & Yahoo Finance
• Dren Bio on LinkedIn, X (Twitter) & YouTube